These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9824483)

  • 1. Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease.
    Onoe Y; Harada M; Tamada K; Abe K; Li T; Tada H; Nomoto K
    Immunology; 1998 Oct; 95(2):248-56. PubMed ID: 9824483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells.
    Krenger W; Rossi S; Piali L; Holländer GA
    Blood; 2000 Jul; 96(1):347-54. PubMed ID: 10891472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production.
    Baker J; Verneris MR; Ito M; Shizuru JA; Negrin RS
    Blood; 2001 May; 97(10):2923-31. PubMed ID: 11342413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional changes of intestinal intraepithelial lymphocytes during acute graft versus host disease: correlation with phenotype.
    Nussler NC; Hoffman RA; McCarthy SA; Simmons RL
    Int Immunol; 1996 Nov; 8(11):1767-77. PubMed ID: 8943572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease.
    Kataoka Y; Iwasaki T; Kuroiwa T; Seto Y; Iwata N; Hashimoto N; Ogata A; Hamano T; Kakishita E
    Immunology; 2001 Jul; 103(3):310-8. PubMed ID: 11454060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA; MacDonald GC; Rector ES; Gartner JG
    J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-18 prevents the development of chronic graft-versus-host disease in mice.
    Okamoto I; Kohno K; Tanimoto T; Iwaki K; Ishihara T; Akamatsu S; Ikegami H; Kurimoto M
    J Immunol; 2000 Jun; 164(11):6067-74. PubMed ID: 10820292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis of thymocytes during acute graft-versus-host disease is independent of glucocorticoids.
    Krenger W; Rossi S; Holländer GA
    Transplantation; 2000 May; 69(10):2190-3. PubMed ID: 10852622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
    Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
    J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.
    Zhang Y; Hexner E; Frank D; Emerson SG
    J Immunol; 2007 Sep; 179(5):3305-14. PubMed ID: 17709547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
    Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
    Thiele DL; Charley MR; Calomeni JA; Lipsky PE
    J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic hormone modulation of age-induced changes in the induction of graft-versus-host disease by DBA/2J lymphocytes.
    Fast LD; Kouttab NM; Badamchian M; Goldstein AL
    Cell Immunol; 1990 Nov; 131(1):232-41. PubMed ID: 2225080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease.
    Via CS; Rus V; Gately MK; Finkelman FD
    J Immunol; 1994 Nov; 153(9):4040-7. PubMed ID: 7930611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
    Koyasu S
    J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.